Anaplastic large cell lymphoma (ALCL), ALK-negative, is a type of non-Hodgkin lymphoma characterized by the proliferation of large atypical lymphoid cells. This condition primarily affects lymph nodes in the head, face, and neck region. Accurate coding with ICD-10 Code C84.71 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this malignancy.
ICD-10 Code C84.71 represents anaplastic large cell lymphoma that is anaplastic lymphoma kinase (ALK) negative, specifically affecting the lymph nodes of the head, face, and neck. This code is used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, which is crucial for treatment planning and healthcare resource allocation.
Anaplastic large cell lymphoma, ALK-negative, is a rare and aggressive form of non-Hodgkin lymphoma that arises from T-cells. It typically presents with lymphadenopathy in the head, face, and neck regions. Prompt diagnosis and treatment are critical due to its potential for rapid progression and systemic involvement.
ICD-10 Code C84.71 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients diagnosed with anaplastic large cell lymphoma. This code aids in capturing the patient's symptoms, guiding clinical decision-making, and ensuring appropriate billing in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C84.71 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of anaplastic large cell lymphoma. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of anaplastic large cell lymphoma, ALK-negative, often requires urgent intervention due to its aggressive nature. Treatment typically involves chemotherapy and may include targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.71 is critical in medical billing, particularly in hospital, ER, or oncology settings, to ensure accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique, for the first hour. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
| 77014 | Radiologic examination, lymph nodes, with contrast. |
Common Questions About Using ICD-10 Code C84.71 for Anaplstc lg cell lymph, ALK-neg, nodes of head, face, and nk
What are the common symptoms of anaplastic large cell lymphoma?
Common symptoms include painless swelling of lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and other systemic symptoms.
How is anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a biopsy of the affected lymph nodes, followed by histological examination and immunophenotyping to confirm the presence of large atypical lymphoid cells and ALK negativity.
What is the treatment for anaplastic large cell lymphoma?
Treatment usually involves chemotherapy, and in some cases, targeted therapies may be used. The specific regimen depends on the patient's overall health and disease stage.
Is anaplastic large cell lymphoma contagious?
No, anaplastic large cell lymphoma is not contagious. It is a type of cancer that arises from the body's immune cells and cannot be transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes